Literature DB >> 31435478

Association of Cardinal Motor Symptoms with Region-Specific Dopamine Transporter Activity in Mild to Moderate Parkinson's Disease.

Martijn L T M Müller1, Roger L Albin2,3,4, Nicolaas I Bohnen1,2,3,4.   

Abstract

OBJECTIVE: To investigate the relationship between measures of the cardinal motor features and the degree of nigrostriatal dopaminergic denervation in patients with mild to moderate Parkinson's disease (PD).
METHODS: PD patients (Hoehn and Yahr stages I-III, n = 27) underwent 11C-β-CFT dopamine transporter (DAT) positron emission tomography. Clinical examination included the Unified PD Rating Scale (UPDRS) motor examination with sub-scores for the cardinal motor features of PD, grooved pegboard, and finger- and foot-tapping scores. Postural sway was also assessed. Patients on dopaminergic drugs were studied in the "off" state.
RESULTS: Lower total striatal DAT binding was associated with higher UPDRS motor scores, slower performance on the grooved pegboard, and higher variability of postural sway. UPDRS subscale scores for rigidity and tremor, and foot- and finger tapping did not significantly correlate with striatal DAT binding. Thalamic DAT binding correlated with finger-tapping (r = 0.532, p = 0.005) and foot-tapping scores (r = 0.474, p = 0.017). Regional striatal analysis showed that ventral striatal DAT binding robustly correlated with UPDRS total motor (r = -0.507, p = 0.007) and grooved pegboard (r = -0.567, p = 0.002) performance. Posturography analysis showed increased sway variability with decreased posterior putamen DAT activity (r = -0.475, p = 0.019).
CONCLUSION: These findings indicate that the nigrostriatal dopaminergic model of PD has limited correlations with the motor features of this disorder. Although nigrostriatal patterns of denervation may explain some of these findings, a more comprehensive model of parkinsonian motor impairments likely involves extra-striatal dopaminergic and non-dopaminergic mechanisms.

Entities:  

Keywords:  11C-β-CFT PET; Basal ganglia; Parkinson’s disease; dopamine; motor functions; posturography; thalamus

Year:  2013        PMID: 31435478      PMCID: PMC6703828     

Source DB:  PubMed          Journal:  Eur Neurol J


  46 in total

1.  Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.

Authors:  J O Rinne; H Ruottinen; J Bergman; M Haaparanta; P Sonninen; O Solin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.

Authors:  Roger L Albin; Thomas E Nichols; Kirk A Frey
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

4.  Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients.

Authors:  A Winogrodzka; R C Wagenaar; P Bergmans; A Vellinga; J Booij; E A van Royen; R E van Emmerik; J C Stoof; E C Wolters
Journal:  Mov Disord       Date:  2001-11       Impact factor: 10.338

5.  Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.

Authors: 
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

6.  Lateral stability, sensorimotor function and falls in older people.

Authors:  S R Lord; M W Rogers; A Howland; R Fitzpatrick
Journal:  J Am Geriatr Soc       Date:  1999-09       Impact factor: 5.562

7.  Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.

Authors:  J S Rakshi; T Uema; K Ito; D L Bailey; P K Morrish; J Ashburner; A Dagher; I H Jenkins; K J Friston; D J Brooks
Journal:  Brain       Date:  1999-09       Impact factor: 13.501

8.  In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.

Authors:  C S Lee; A Samii; V Sossi; T J Ruth; M Schulzer; J E Holden; J Wudel; P K Pal; R de la Fuente-Fernandez; D B Calne; A J Stoessl
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

9.  Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease.

Authors:  L Rocchi; L Chiari; F B Horak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

10.  Postural instability in idiopathic Parkinson's disease: the role of medication and unilateral pallidotomy.

Authors:  Helen M Bronte-Stewart; A Yuriko Minn; Kamala Rodrigues; Ellie L Buckley; Lewis M Nashner
Journal:  Brain       Date:  2002-09       Impact factor: 13.501

View more
  1 in total

1.  Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Robert A Koeppe; Carlos A Sanchez-Catasus; Kirk A Frey; Peter Scott; Gregory M Constantine; Roger L Albin; Martijn L T M Müller
Journal:  Brain Commun       Date:  2021-05-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.